As the pan-European STOXX Europe 600 Index ended higher, breaking a streak of losses, investors are cautiously optimistic amid mixed signals from global economic policies and trade tensions. In this environment, identifying stocks that may be undervalued can offer potential opportunities for those looking to navigate the complexities of market fluctuations and economic uncertainties. Top 10 Undervalued Stocks Based On Cash Flows In Europe Name Current Price Fair Value (Est) Discount (Est) Absolent Air Care Group (OM:ABSO) SEK260.00 SEK511.61 49.2% Romsdal Sparebank (OB:ROMSB) NOK130.30 NOK259.93 49.9% Vimi Fasteners (BIT:VIM) €0.97 €1.91 49.2% CTT Systems (OM:CTT) SEK221.00 SEK440.81 49.9% Comet Holding (SWX:COTN) CHF233.00 CHF464.46 49.8% Net Insight (OM:NETI B) SEK4.82 SEK9.58 49.7% Deutsche Beteiligungs (XTRA:DBAN) €26.55 €53.05 50% dormakaba Holding (SWX:DOKA) CHF681.00 CHF1356.93 49.8% Melhus Sparebank (OB:MELG) NOK167.04 NOK329.29 49.3% Neosperience (BIT:NSP) €0.532 €1.06 49.7% Click here to see the full list of 212 stocks from our Undervalued European Stocks Based On Cash Flows screener. Let's review some notable picks from our screened stocks. Altri SGPS Overview: Altri SGPS is a company that produces and sells cellulosic fibers both in Portugal and internationally, with a market cap of €1.28 billion. Operations: The company's revenue primarily comes from the production and commercialization of cellulosic fibers, totaling €710.40 million. Estimated Discount To Fair Value: 43.1% Altri SGPS is trading at €6.23, significantly below its estimated fair value of €10.95, suggesting it may be undervalued based on cash flows. Recent earnings results show strong net income growth from €42.8 million to €107.2 million year-over-year, highlighting robust profitability despite revenue growing slower than 20% annually. However, interest payments are not well covered by earnings and the dividend track record is unstable, which could pose risks to potential investors seeking stability in returns. The analysis detailed in our Altri SGPS growth report hints at robust future financial performance. Click here to discover the nuances of Altri SGPS with our detailed financial health report.ENXTLS:ALTR Discounted Cash Flow as at Mar 2025 BlueNord Overview: BlueNord ASA is an oil and gas company engaged in the exploration, development, and production of hydrocarbon resources across Norway, Denmark, the Netherlands, and the United Kingdom with a market cap of NOK17.60 billion. Operations: The company's revenue is primarily generated from its Oil & Gas - Exploration & Production segment, amounting to $702.30 million. Story Continues Estimated Discount To Fair Value: 39.3% BlueNord ASA, trading at NOK664, is significantly below its estimated fair value of NOK1094.56, indicating it is undervalued based on cash flows. Despite a recent net loss of US$70.8 million for 2024 and interest payments not well covered by earnings, the company is forecast to achieve high profitability growth over the next three years. Recent operational challenges at Tyra II are expected to be resolved soon, potentially enhancing production efficiency and financial performance going forward. Our earnings growth report unveils the potential for significant increases in BlueNord's future results. Click to explore a detailed breakdown of our findings in BlueNord's balance sheet health report.OB:BNOR Discounted Cash Flow as at Mar 2025 Bonesupport Holding Overview: Bonesupport Holding AB (publ) is an orthobiologics company that develops and commercializes injectable bio-ceramic bone graft substitutes across Europe, North America, and internationally, with a market cap of SEK21.85 billion. Operations: The company's revenue primarily comes from its Pharmaceuticals segment, generating SEK898.73 million. Estimated Discount To Fair Value: 42.8% Bonesupport Holding, trading at SEK331.8, is significantly undervalued with an estimated fair value of SEK580.34 based on cash flow analysis. Despite a decrease in net profit margin from 41.5% to 14.9% over the past year, its earnings and revenue are forecast to grow substantially faster than the Swedish market over the next three years. Recent positive study results for CERAMENT products may bolster future growth prospects and enhance profitability further. Upon reviewing our latest growth report, Bonesupport Holding's projected financial performance appears quite optimistic. Unlock comprehensive insights into our analysis of Bonesupport Holding stock in this financial health report.OM:BONEX Discounted Cash Flow as at Mar 2025 Seize The Opportunity Click through to start exploring the rest of the 209 Undervalued European Stocks Based On Cash Flows now. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Ready For A Different Approach? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTLS:ALTR OB:BNOR and OM:BONEX. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
March 2025's European Stocks Possibly Priced Below Their Estimated Value
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...